FDA tells doctors to discuss overdose antidote with patients
The move by the Food and Drug Administration is the latest government effort to increase use of the drug naloxone, which can counteract the effects of an opioid overdose in minutes.
The move by the Food and Drug Administration is the latest government effort to increase use of the drug naloxone, which can counteract the effects of an opioid overdose in minutes.
AlleyCorp is looking to create an ecosystem of digital health companies in New York City.
The average total compensation for CEOs of the major health insurance companies increased 5.7% to $20.6 million last year, according to regulatory filings.
Industry-wide challenges have the private-equity-backed physicians group grappling with high debt loads.
Yale alleges Prospect hasn’t paid clinicians and vendors, let the state of its facilities decline and is in danger of losing a Medicare contract.
HHS announced Friday it would publish a final rule extending Obamacare access to people under the Deferred Action for Childhood Arrivals program, or DACA.
Here is what five telehealth executives and investors had to say about Walmart and others exiting virtual care.
General Catalyst, Providence’s venture arm and 7WireVentures were among the notable digital health investors this week.
UnitedHealth Group is rebuilding some Change Healthcare systems from scratch, a time-consuming process given the volume and complexity of its platforms.
Amazon’s One Medical CEO Trent Green said the primary care provider has its eye on expansion.
The deal marks just the latest acquisition made by Northfield-based Medline under its new CEO.